Week 4: end of a typical research planning cycle and reasonable review point
Wegovy highlights of prescribing information, Food and Drug Administration (2024) Trulicity highlights of prescribing information, Food and Drug Administration (2022) An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg, Diabetes, Obesity and Metabolism (2021) Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity, JAMA Network Open (2022) The effect of dulaglutide on glycemic and weight control in patients with type 2 diabetes, Medicine and Pharmacy Reports (2023) Label: Wegovy, DailyMed (2024) Label: Trulicity, DailyMed (2023) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Symptoms like congestion, fatigue and brain fog can derail productivity
Additionally, semaglutide influences hormones beyond appetite control, including those that regulate sleep-wake cycles and energy distribution throughout the day
The sleep-promoting effects lasted up to 6 hours through the night
